SCHEMBL30833395

SCHEMBL30833395

CC(C)(C)OC(=O)N1CCCCC1CS(=O)(=O)c1cccc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
DRD2 P14416 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
SLC6A2 P23975 1/20 0.46
HRH2 P25021 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR7 P34969 1/20 0.46
DRD3 P35462 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
PSEN1 P49768 1/20 0.46
SLC6A3 Q01959 1/20 0.46
TMEM97 Q5BJF2 1/20 0.46
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833419 0.83 RIPK1 (0.47) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL30833390 0.82 OPRD1 (0.44) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL20828162 0.82 GPR119 (0.48) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL17942389 0.81 TGFBR1 (0.53) GPR119
SCHEMBL30833386 0.80 RIPK1 (0.45) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL30833425 0.80 RIPK1 (0.45) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL30833481 0.80 NR1H3 (0.48) RIPK1NR1H2NR1H3GPR119MEN1
SCHEMBL1763578 0.79 LMNA (0.47) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL1763583 0.79 LMNA (0.47) APPHTR1AADRA2ADRD2ADRA2B
SCHEMBL30833401 0.78 KDM1A (0.44) APPHTR1AADRA2ADRD2ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118164961-A 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-06-11 CN disclosed
CN-111393414-B 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-05-07 CN disclosed